225 related articles for article (PubMed ID: 27513223)
1. Comparison of the Tolerability of Diclofenac and Nepafenac.
Achiron A; Karmona L; Mimouni M; Gershoni A; Dzhanov Y; Gur Z; Burgansky Z
J Ocul Pharmacol Ther; 2016 Nov; 32(9):601-605. PubMed ID: 27513223
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
Colin J; Paquette B
Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
[TBL] [Abstract][Full Text] [Related]
3. Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use.
Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19743570
[No Abstract] [Full Text] [Related]
4. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Trattler W; McDonald M
Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
[TBL] [Abstract][Full Text] [Related]
5. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
Ylinen P; Taipale C; Lindholm JM; Laine I; Holmström E; Tuuminen R
Acta Ophthalmol; 2018 Dec; 96(8):853-859. PubMed ID: 30284393
[TBL] [Abstract][Full Text] [Related]
6. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
7. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
Lane SS; Modi SS; Lehmann RP; Holland EJ
J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
[TBL] [Abstract][Full Text] [Related]
8. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA
J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.
Zhao X; Xia S; Wang E; Chen Y
PLoS One; 2017; 12(3):e0173254. PubMed ID: 28253334
[TBL] [Abstract][Full Text] [Related]
11. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Lindstrom R; Holland E; Lane S; Raizman M; Reilly C
Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
[No Abstract] [Full Text] [Related]
12. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
Cagini C; Pellegrino A; Cerquaglia A; Iaccheri B; Lupidi M; Fiore T
Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437
[TBL] [Abstract][Full Text] [Related]
13. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Toyos R
Cornea; 2008 Apr; 27(3):384; author reply 384-5. PubMed ID: 18362678
[No Abstract] [Full Text] [Related]
14. Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
Singh RP; Lehmann R; Martel J; Jong K; Pollack A; Tsorbatzoglou A; Staurenghi G; Cervantes-Coste Cervantes G; Alpern L; Modi S; Svoboda L; Adewale A; Jaffe GJ
Ophthalmology; 2017 Jun; 124(6):776-785. PubMed ID: 28268098
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial.
Caldwell M; Reilly C
J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088
[TBL] [Abstract][Full Text] [Related]
16. Ketorolac versus nepafenac in cataract surgery.
McCulley JP
J Cataract Refract Surg; 2008 Mar; 34(3):345-6; author reply 346. PubMed ID: 18299048
[No Abstract] [Full Text] [Related]
17. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
Lindstrom R; Kim T
Curr Med Res Opin; 2006 Feb; 22(2):397-404. PubMed ID: 16466612
[TBL] [Abstract][Full Text] [Related]
18. Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
Georgakopoulos CD; Plotas P; Kagkelaris K; Tsapardoni F; Makri OE
J Ocul Pharmacol Ther; 2019 Apr; 35(3):168-173. PubMed ID: 30688558
[TBL] [Abstract][Full Text] [Related]
19. 0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.
Oğurel T; Oğurel R; Onaran Z; Örnek K
Cont Lens Anterior Eye; 2018 Oct; 41(5):448-451. PubMed ID: 29807771
[TBL] [Abstract][Full Text] [Related]
20. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
